Wells Fargo & Company Rockwell Medical, Inc. Transaction History
Wells Fargo & Company
- $410 Billion
- Q1 2024
A detailed history of Wells Fargo & Company transactions in Rockwell Medical, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 813 shares of RMTI stock, worth $1,569. This represents 0.0% of its overall portfolio holdings.
Number of Shares
813
Previous 809
0.49%
Holding current value
$1,569
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding RMTI
# of Institutions
41Shares Held
5.45MCall Options Held
20.9KPut Options Held
47.3K-
Armistice Capital, LLC New York, NY2.63MShares$5.08 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.12MShares$2.16 Million0.0% of portfolio
-
Perkins Capital Management Inc349KShares$672,9600.5% of portfolio
-
Richmond Brothers, Inc. Jackson, MI322KShares$621,9441.01% of portfolio
-
Geode Capital Management, LLC Boston, MA289KShares$557,3060.0% of portfolio
About ROCKWELL MEDICAL, INC.
- Ticker RMTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 10,675,200
- Market Cap $20.6M
- Description
- Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iro...